At a time when obesity and diabetes are posing ever greater challenges for the healthcare system worldwide, innovative therapies are being hotly debated. One of these is currently causing a stir: the so-called "weight loss injection". But what can this new medical option really do? Is it a breakthrough in the fight against obesity and diabetes or just another interim step? To shed light on this, we rely on a direct exchange between research, clinical practice and the personal experiences of those affected.

Prof. Dr. med. Dr. h.c. Matthias Tschöp, CEO of Helmholtz Munich and the world's leading expert in diabetes research, will explain the scientific background and potential of this innovative treatment. Prof. Dr. med. Matthias Blüher, Head of the Obesity Research Group at the University of Leipzig, sees obesity sufferers in daily practice and will give a well-founded overview of the clinical application and current status of the therapy. A patient will give a first-hand account of her experiences with obesity and the effects of new forms of treatment.

Join us as experts and patients discuss the future of obesity therapy. Discuss with us: Can weight loss injections really mean the end of extreme obesity and diabetes? What are the opportunities and risks? An evening full of information, discussions and new perspectives awaits you.

Prof. Dr. med. Dr. h.c. Matthias Tschöp is CEO of Helmholtz Munich and a leading expert in the research of metabolic diseases, in particular diabetes and obesity. He holds a doctorate in medicine and has developed several innovative therapies targeting hormonal balance to treat metabolic disorders.

Prof. Dr. med. Matthias Blüher is Director of the Department of Endocrinology and Nephrology at the University of Leipzig and an expert in obesity research. He has a particular focus on the role of adipose tissue and insulin resistance in metabolic diseases and is one of the leading scientists in this field.

About Helmholtz Munich:

Helmholtz Munich is a biomedical research center of excellence. Its mission is to develop breakthrough solutions for a healthier society in a rapidly changing world. Interdisciplinary research teams focus on environmental diseases, in particular the treatment and prevention of diabetes, obesity, allergies and chronic lung diseases. Using artificial intelligence and bioengineering, the researchers transfer their findings to patients more quickly. Helmholtz Munich has around 2,500 employees and is based in Munich/Neuherberg. It is a member of the Helmholtz Association, the largest scientific organization in Germany with more than 43,000 employees and 18 research centers.

Moderation: Maximilian Maier

Admission: 18:30

Start: 19:00

End: 21:00 hrs

Tickets:

Fair-Price Ticket: 24,00€

This price ensures that all participants are paid fairly and can make a living from their work. If you can afford it, we would be delighted if you bought this ticket.

Social-Price Ticket: 15,00€

Culture costs money, but should not exclude anyone. That's why this ticket is intended for people who have little financial leeway - for whatever reason.